Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Acquisition of Shares of CardioComm Solutions, Inc.

December 29, 2010 4:45 am | by The Associated Press | News | Comments

Dr. Anatoly Langer, the Chairman of CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), today announced that he acquired, through MD Primer Inc., a company under his control, 6,000,000 common shares of the Company and 6,000,000 common share purchase warrants of...

CardioComm Solutions, Inc. Announces Closing of Private Placement Equity Financing

December 29, 2010 4:45 am | by The Associated Press | News | Comments

CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company") today announced that it has closed its previously announced non-brokered private placement equity financing. Under the financing, the Company issued 6,000,000 units at a price of $0.05 per unit for gross...

Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy

December 29, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Dec. 29, 2010 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of...

TOPICS:
Advertisement

Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication

December 29, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa., Dec. 29, 2010 /- Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to...

TOPICS:

Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials - Recall Due to Particulates in Some Vials

December 29, 2010 4:31 am | by U.S. Food & Drug Administration | News | Comments

Nationwide recall initiated December 23 due to some vials of these lots contain particulates.

TOPICS:

SXC completes $100 million buyout of MedfusionRx

December 29, 2010 2:45 am | by The Associated Press | News | Comments

Pharmacy benefits manager SXC Health Solutions Corp. said Wednesday it completed the buyout of specialty pharmacy provider MedfusionRx LCC for $100 million.The company announced the buyout Dec. 2. The deal includes up to an additional $5.5 million if certain performance targets are achieved...

GenVec Forms Collaboration With World-Leading Animal Health Company

December 29, 2010 2:35 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., Dec. 29, 2010 /- GenVec, Inc. (Nasdaq: GNVC ) today announced that the company will be working with Merial to develop and commercialize GenVec's proprietary vaccine technology for use against foot-and-mouth disease (FMD). Merial is the leading FMD vaccine producer in...

TOPICS:

New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011(2)

December 28, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

LUBBOCK, Texas, Dec. 28, 2010 /- The MED Group, a Managed Health Care Associates, Inc. (MHA) Company, announces the creation of www.medicaresuppliersnetwork.com .  The website was created to help answer questions for Medicare beneficiaries and referral sources, such as physician...

TOPICS:
Advertisement

LuxteL Brand Is the Longest Standing Recognized Name in the Industry

December 28, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

DANVERS, Mass., Dec. 28, 2010 /- LuxteL llc , a quality manufacturer of reliable illumination products made in the USA, announces that, with the recent sale of their only remaining manufacturing competitor, LuxteL is now the oldest recognized name in the Ceramic Lighting business. Since...

TOPICS:

Crothall Healthcare Selects 3Mâ„¢ Clean-Traceâ„¢ for Infection Control Verification

December 28, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., Dec. 28, 2010 /- Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control. Crothall Environmental Services teams will use a...

TOPICS:

New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011

December 28, 2010 10:34 am | News | Comments

LUBBOCK, Texas, Dec. 28, 2010 /- The MED Group, a Managed Health Care Associates, Inc. (MHA) Company, announces the creation of www.medicaresuppliersnetwork.com .  The website was created to help answer questions for Medicare beneficiaries and referral sources, such as physician...

MIT scientists develop bladder disease device

December 28, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

MIT researchers have developed a pretzel-shaped device designed to treat interstitial cystitis, a bladder disease noted for causing frequent and painful urination predominantly in women, the MIT News Office reported Monday.

Miss. hospital to acquire second medical center

December 28, 2010 8:46 am | by The Associated Press | News | Comments

Anderson Regional Medical Center has completed its purchase of Riley Hospital from Health Management Associates Inc.Both hospitals are located in Meridian. Terms of the purchase were not released Tuesday.Anderson president/CEO L. Ray Humphreys says the acquisition is expected to be finalized by...

FDA warns Smith & Nephew over orthopedic plant

December 28, 2010 8:45 am | by The Associated Press | News | Comments

The Food and Drug Administration has issued a warning letter to orthopedic maker Smith & Nephew PLC over manufacturing problems uncovered at a plant in Germany earlier this year.Government inspectors visited the company's Tuttlingen, Germany plant in July and cited the company for several...

Spencer Pharmaceutical adds Buschmann to science board

December 28, 2010 8:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Spencer Pharmaceutical Inc., a metabolic disease-focused firm in Boston, has appointed Michael Buschmann, director of the FRSQ Group in Biomedical Science and Technology, to Spencer's scientific advisory board.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading